Literature DB >> 23979814

Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma.

Ping L Zhang1, Joseph W Mashni, Venkata S Sabbisetti, Charles M Schworer, George D Wilson, Stacy C Wolforth, Kenneth M Kernen, Brian D Seifman, Mitual B Amin, Timothy J Geddes, Fan Lin, Joseph V Bonventre, Jason M Hafron.   

Abstract

BACKGROUND: KIM-1 staining is upregulated in proximal tubule-derived renal cell carcinoma (RCC) including clear renal cell carcinoma and papillary renal cell carcinoma, but not in chromophobe RCC (distal tubular tumor). This study was designed to prospectively examine urine KIM-1 level before and 1 month after removal of renal tumors. PATIENTS AND
DESIGN: A total of 19 patients were eventually enrolled in the study based on pre-operative imaging studies. Pre-operative and follow-up (1 month) urine KIM-1 levels were measured. The urine KIM-1 levels (uKIM-1) were then normalized to urine creatinine levels (uCr). Renal tumors were also stained for KIM-1 using immunohistochemical techniques.
RESULTS: The KIM-1-negative staining group included 7 cases, and the KIM-1-positive group consisted of 12 cases. The percentage of KIM-1-positive staining RCC cells ranged from 10 to 100 %, and the staining intensity ranged from 1+ to 3+. In both groups, serum creatinine levels were both significantly elevated after nephrectomy. In the KIM-1-negative group, uKIM-1/uCr remained at a similar level before (0.37 ± 0.1 ng/mg Cr) and after nephrectomy (0.32 ± 0.01 ng/mg Cr). However, in the KIM-1-positive group, elevated uKIM-1/uCr at 1.20 ± 0.31 ng/mg Cr was significantly reduced to 0.36 ± 0.1 ng/mg Cr, which was similar to the pre-operative uKIM-1/uCr (0.37 ± 0.1 ng/mg Cr) in the KIM-1-negative group.
CONCLUSION: Our small but prospective study showed significant reduction in uKIM-1/uCr after nephrectomy in the KIM-1 positive group, suggesting that urine KIM-1 may serve as a surrogate biomarker for kidney cancer and a non-invasive pre-operative measure to evaluate the malignant potential of renal masses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23979814      PMCID: PMC4066455          DOI: 10.1007/s11255-013-0522-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  26 in total

Review 1.  Autophagy and disease: always two sides to a problem.

Authors:  Sunandini Sridhar; Yair Botbol; Fernando Macian; Ana Maria Cuervo
Journal:  J Pathol       Date:  2011-11-23       Impact factor: 7.996

2.  Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.

Authors:  Vishal S Vaidya; Josef S Ozer; Frank Dieterle; Fitz B Collings; Victoria Ramirez; Sean Troth; Nagaraja Muniappa; Douglas Thudium; David Gerhold; Daniel J Holder; Norma A Bobadilla; Estelle Marrer; Elias Perentes; André Cordier; Jacky Vonderscher; Gérard Maurer; Peter L Goering; Frank D Sistare; Joseph V Bonventre
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

3.  Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury.

Authors:  P L Zhang; L I Rothblum; W K Han; T M Blasick; S Potdar; J V Bonventre
Journal:  Kidney Int       Date:  2007-12-26       Impact factor: 10.612

4.  Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time.

Authors:  Andrea B Kramer; Mirjan M van Timmeren; Theo A Schuurs; Vishal S Vaidya; Joseph V Bonventre; Harry van Goor; Gerjan Navis
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-18

5.  Tubular epithelial cells have the capacity to transdifferentiate into CD68-positive macrophage-like cells by oxidative stress.

Authors:  M Tanaka; Y Suzuki; I Shirato; H Takahara; T Shibata; T Sugaya; K Shimamoto; S Horikoshi; Y Tomino
Journal:  Inflamm Res       Date:  2008-12       Impact factor: 4.575

6.  Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells.

Authors:  Takaharu Ichimura; Edwin J P V Asseldonk; Benjamin D Humphreys; Lakshman Gunaratnam; Jeremy S Duffield; Joseph V Bonventre
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

7.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

8.  Up-regulated renal expression of TNF-alpha signalling adapter proteins in lupus glomerulonephritis.

Authors:  L Zhu; X Yang; Y Ji; W Chen; W Guan; S F Zhou; X Yu
Journal:  Lupus       Date:  2009-02       Impact factor: 2.911

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  Kim-1/Tim-1 and immune cells: shifting sands.

Authors:  Takaharu Ichimura; Craig R Brooks; Joseph V Bonventre
Journal:  Kidney Int       Date:  2012-05       Impact factor: 10.612

View more
  9 in total

1.  KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.

Authors:  Ghislaine Scelo; David C Muller; Elio Riboli; Mattias Johansson; Amanda J Cross; Paolo Vineis; Konstantinos K Tsilidis; Paul Brennan; Heiner Boeing; Petra H M Peeters; Roel C H Vermeulen; Kim Overvad; H Bas Bueno-de-Mesquita; Gianluca Severi; Vittorio Perduca; Marina Kvaskoff; Antonia Trichopoulou; Carlo La Vecchia; Anna Karakatsani; Domenico Palli; Sabina Sieri; Salvatore Panico; Elisabete Weiderpass; Torkjel M Sandanger; Therese H Nøst; Antonio Agudo; J Ramón Quirós; Miguel Rodríguez-Barranco; Maria-Dolores Chirlaque; Timothy J Key; Prateek Khanna; Joseph V Bonventre; Venkata S Sabbisetti; Rupal S Bhatt
Journal:  Clin Cancer Res       Date:  2018-07-23       Impact factor: 12.531

2.  Combining Extracellular miRNA Determination with Microfluidic 3D Cell Cultures for the Assessment of Nephrotoxicity: a Proof of Concept Study.

Authors:  Laura Suter-Dick; L Mauch; D Ramp; M Caj; M K Vormann; S Hutter; H L Lanz; J Vriend; R Masereeuw; M J Wilmer
Journal:  AAPS J       Date:  2018-07-23       Impact factor: 4.009

3.  Tissue and urinary KIM-1 relate to tumor characteristics in patients with clear renal cell carcinoma.

Authors:  Mirjana Mijuskovic; Ivan Stanojevic; Novak Milovic; Snezana Cerovic; Dejan Petrovic; Djoko Maksic; Bozidar Kovacevic; Tamara Andjelic; Predrag Aleksic; Brankica Terzic; Mirjana Djukic; Danilo Vojvodic
Journal:  Int Urol Nephrol       Date:  2017-10-19       Impact factor: 2.370

4.  Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805).

Authors:  Wenxin Xu; Mäneka Puligandla; Brian Halbert; Naomi B Haas; Keith T Flaherty; Robert G Uzzo; Janice P Dutcher; Robert S DiPaola; Venkata Sabbisetti; Rupal S Bhatt
Journal:  Clin Cancer Res       Date:  2021-04-08       Impact factor: 12.531

5.  Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma.

Authors:  Jasper C Lee; Demitra M Yotis; Ji Yun Lee; Marie A Sarabusky; Bradly Shrum; Audrey Champagne; Ola Z Ismail; Elena Tutunea-Fatan; Hon S Leong; Lakshman Gunaratnam
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

6.  Human kidney injury molecule-1 as a urine biomarker differentiating urothelial and renal cell carcinoma.

Authors:  Łukasz Białek; Michał Niemczyk; Katarzyna Czerwińska; Mateusz Nowak; Anna Sadowska; Tomasz Borkowski; Piotr Radziszewski; Jakub Dobruch; Piotr Kryst; Sławomir Poletajew
Journal:  Cent European J Urol       Date:  2021-07-07

Review 7.  The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity.

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Smaranda Radu; Claudia Florida Costea; Manuela Ciocoiu; Alexandru Carauleanu; Cristina Mihaela Lacatusu; Minela Aida Maranduca; Mariana Floria; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2019-10-22       Impact factor: 5.923

8.  HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome.

Authors:  Ji Xue; Ying Li; Jianfeng Yi; Hong Jiang
Journal:  Gastroenterol Res Pract       Date:  2019-12-02       Impact factor: 2.260

Review 9.  Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker (Review).

Authors:  Т А Karmakova; N S Sergeeva; К Yu Kanukoev; B Ya Alekseev; А D Kaprin
Journal:  Sovrem Tekhnologii Med       Date:  2021-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.